D.E. Shaw & Co’s Krystal Biotech KRYS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$257K Sell
996
-1,112
-53% -$296K ﹤0.01% 4119
2025
Q4
$520K Sell
2,108
-4,706
-69% -$990K ﹤0.01% 3913
2025
Q3
$1.2M Sell
6,814
-4,913
-42% -$735K ﹤0.01% 3346
2025
Q2
$1.61M Sell
11,727
-38,165
-76% -$5.61M ﹤0.01% 2903
2025
Q1
$9M Buy
49,892
+42,465
+572% +$7.14M 0.01% 1477
2024
Q4
$1.16M Sell
7,427
-1,919
-21% -$340K ﹤0.01% 3117
2024
Q3
$1.7M Sell
9,346
-1,700
-15% -$328K ﹤0.01% 2833
2024
Q2
$2.03M Sell
11,046
-70,981
-87% -$11.9M ﹤0.01% 2646
2024
Q1
$14.6M Buy
82,027
+14,886
+22% +$2.07M 0.02% 1119
2023
Q4
$8.33M Buy
67,141
+11,384
+20% +$1.26M 0.01% 1500
2023
Q3
$6.47M Buy
55,757
+45,962
+469% +$5.61M 0.01% 1600
2023
Q2
$1.15M Buy
9,795
+4,200
+75% +$429K ﹤0.01% 2996
2023
Q1
$448K Sell
5,595
-805
-13% -$63.2K ﹤0.01% 3601
2022
Q4
$507K Sell
6,400
-1,700
-21% -$126K ﹤0.01% 3841
2022
Q3
$565K Hold
8,100
﹤0.01% 3969
2022
Q2
$532K Buy
8,100
+4,291
+113% +$267K ﹤0.01% 4053
2022
Q1
$253K Buy
+3,809
New +$238K ﹤0.01% 4740
2021
Q4
Sell
-13,571
Closed -$709K 5579
2021
Q3
$709K Buy
13,571
+6,331
+87% +$375K ﹤0.01% 3859
2021
Q2
$492K Buy
+7,240
New +$505K ﹤0.01% 4042

Other funds holding KRYS